ArticleCureus2024
Comparison of E-Cadherin Expression in Oral Verrucous Carcinoma and Normal Oral Mucosa: An Immunohistochemical Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Oral verrucous carcinoma (OVC), a low-grade variation of oral squamous cell carcinoma (OSCC), is distinguished by endophytic development and a pebbly, mammillated surface. OVC, often referred to as Ackerman's tumor, has been known to involve lymph nodes but rarely spreads to regional and distant locations; when the primary tumor grows, it frequently involves surrounding tissues. Histopathologically, it has a thicker basement membrane, many reduplications, and a large area of inflammatory infiltration that resembles OSCC. Therefore, precise histological diagnosis of verrucous carcinoma is crucial as helps in identifying tumors with a higher propensity to develop into OSCC. In cancer progression, the epithelial-mesenchymal transition (EMT) is the most important stage. One factor influencing EMT is epithelial cadherin (E-cadherin). Thus, it is imperative to identify indicators that can facilitate the detection of lesions with the potential to progress into OSCC. Aim This study aimed to identify the expression of E-cadherin in normal mucosa and verrucous carcinoma and determine its role in the progression of the lesion. Methodology A total of 15 subjects with normal mucosa and 15 subjects with verrucous carcinoma were histopathologically examined and confirmed. Tissue sections were stained immunohistochemically with E-cadherin, utilizing the normal mucosa as the control group. Results When comparing normal oral mucosa to oral verrucous carcinoma, a decrease in E-cadherin expression was noted. Nonetheless, a statistically significant connection was identified between clinical parameters and E-cadherin expression solely concerning gender. Conclusion Through this study, we have attempted to assess and correlate the expression of E-cadherin between OVC and normal oral mucosa with clinical parameters. Furthermore, compared to normal oral mucosa, there was a significant decrease in the expression of E-cadherin in OVC. While further research with an extensive panel of biomarkers and a larger sample size could yield a greater understanding of carcinogenesis mechanisms, E-cadherin serves as a significant marker in partially evaluating the carcinogenic process of oral cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.